Sarcopenia Nearly Doubles Risk Women Will Quit Endocrine Therapy Sarcopenia Nearly Doubles Risk Women Will Quit Endocrine Therapy

But the good news is oncologists can address the condition before starting therapy. The study was published as a preprint and has not yet been peer reviewed.First Look
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news